ANALYST-UPGRADE ·Filed Jun 24, 2026
CICC initiates coverage on MRK at Outperform
MRK drugs
MRK drug pipeline →- ● ENFLONSIA 4/10 Approved · PDUFA date Mar 22, 2027
- ● IDVYNSO 4/10 Approved · PDUFA date Apr 22, 2027
- ▲ sac-TMT 6/10 Filed/PDUFA (Phase 3 data complete; BLA under priority review) · PDUFA date Jun 15, 2027
- ● GARDASIL 4/10 Approved
- ● LAGEVRIO 4/10 EUA (Emergency Use Authorization) / Marketed
- 15 more · All MRK drugs, catalysts & trials →
Price Chart
Loading chart...
Executive Summary
CICC initiates coverage on MRK at Outperform
Impact Score
Base Score
2/7
LLM Adjustment
+0
Final Score
2/10
Consensus & Targets
Buy / Strong Buy
25 (69%)
Hold
11
Sell / Strong Sell
0
Total Analysts
27
Mean PT
$130.11
Median PT
$135.00
High PT
$150.00
Low PT
$100.00
Current Price
$119.60
Implied Upside
+8.8%
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-24 | CICC | initiate | Outperform | $138.00 |
| 2026-05-01 | Wells Fargo | maintain | Overweight | $145.00 |
| 2026-04-13 | UBS | maintain | Buy | $145.00 |
| 2026-04-06 | JP Morgan | maintain | Overweight | $135.00 |
| 2026-03-30 | RBC Capital | reiterate | Outperform | $142.00 |
| 2026-03-20 | Citigroup | maintain | Neutral | $125.00 |
| 2026-03-12 | Wells Fargo | maintain | Overweight | $150.00 |
| 2026-02-25 | RBC Capital | initiate | Outperform | $142.00 |
| 2026-02-20 | Barclays | initiate | Overweight | $140.00 |
| 2026-02-09 | Freedom Broker | maintain | Hold | $110.00 |
Firm Track Record: CICC
CICC accuracy: 55% on 31 calls | avg return: 1.4%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 12 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Deutsche Bank | 100% | 2/2 | 9.7% | top tier |
| BMO Capital | 50% | 2/4 | 0.7% | below average |
| Morgan Stanley | 43% | 3/7 | 2.8% | below average |
| Wells Fargo | 40% | 2/5 | 3.8% | below average |
| B of A Securities | 33% | 1/3 | -0.2% | below average |
| Guggenheim | 25% | 1/4 | -7.8% | below average |
| Truist Securities | 20% | 1/5 | -10.3% | below average |
| Cantor Fitzgerald | 9% | 1/11 | -5.5% | below average |
| Barclays | 0% | 0/2 | -7.6% | below average |
| Berenberg | 0% | 0/2 | 11.6% | below average |
Earnings Estimates
Next earnings: Aug 4, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $2.31 | $2.11 to $2.56 | $17.5B | ↑1 ↓0 |
| 0y | $2.74 | $2.61 to $2.92 | $66.8B | ↑0 ↓0 |
| +1y | $9.56 | $8.90 to $9.87 | $70.2B | ↑0 ↓0 |
| 0q | $-0.15 | $-0.33 to $0.01 | $16.4B | ↑0 ↓0 |
Cross-Platform Signals
Institutional
Pacer Advisors, Inc.: near_exit (-83.2%)
Institutional
NORGES BANK: exit (-100%)
Institutional
MATRIX ASSET ADVISORS INC/NY: trim (-41.6%)
Short Interest
Short: 2,483,659 | Exempt: 3,589 | TRF Vol: 4,427,571 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
34 reports on MRK
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.92% at T+20 after the Aug 6, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $147.76 Now $144.46 −2.23% settles Feb 11
- Nov 9, 20268d ago PTAB Trial Neutral 2/10 Entry $148.05 Now $144.46 −2.42% settles Feb 8
- Nov 3, 202613d ago 3 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
- Nov 3, 202613d ago Institutional Cluster Bearish 4/10 Entry $144.67 Now $144.46 +0.15% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $146.33 Now $144.46 −1.28% settles Jan 27
- Oct 22, 202625d ago 3/A Neutral 1/10 Entry $145.27 Now $144.46 −0.56% settles Jan 21
- Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $147.24 Now $144.46 −1.89% settles Jan 20
- Oct 15, 20264w ago PTAB Trial Bullish 6/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
- Oct 15, 20264w ago PTAB Trial Bullish 5/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
Showing 10 of 34
US Market Status
Market Closed · Opens Wed (10h 41m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers